MedDataX Logo

Rehabilitation Care for Hip Fracture

NCT ID: NCT01934946

Last Updated: 2013-09-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-09-30

Study Completion Date

2014-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose: Hip fracture is a common disease on elderly. They become disabled easily if no adequate rehabilitation was given. The aim of the study is to compare the effectiveness of different types of post acute rehabilitation care for hip fracture.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Method: This study will recruit 150 peoples with hip fracture from hospitals in Taipei from Jan 1, 2014 to Dec 31, 2014. The subjects from wards are randomly divided into group A, B and Group C. Each group includes 50 cases of hip fracture. Group C received 14 days hospitalization for comprehensive rehabilitation and 6 times home rehabilitation services within 3 months; Group B received 14 days hospitalization for comprehensive rehabilitation and Group A was control group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Fracture

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

hip fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

comprehensive rehabilitation 10 days

comprehensive rehabilitation PT OT once per day for 10 times within 14 days hospitalization

Group Type EXPERIMENTAL

comprehensive rehabilitation

Intervention Type OTHER

received 14 days hospitalization for comprehensive rehabilitation

home rehabilitation

home rehabilitation 6 times of PT home visit within 3 months after discharge

Group Type PLACEBO_COMPARATOR

home rehabilitation

Intervention Type OTHER

6 times home rehabilitation services within 3 months

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

comprehensive rehabilitation

received 14 days hospitalization for comprehensive rehabilitation

Intervention Type OTHER

home rehabilitation

6 times home rehabilitation services within 3 months

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. more than 60 years old,
2. hip fracture s/p within 3 months,
3. potential for rehabilitation.

Exclusion Criteria

1. Active infection, such as pneumonia, UTI, osteomyelitis, wound infection
2. Other uncontrolled medical condition, such as, dyspnea on exertion, acute renal failure, acute coronary syndrome, acute heart failure, uncontrolled diabetes, active malignancy, DVT, possibility of pulmonary embolism, acute psychosis
3. No caregiver
4. No potential for rehabilitation, such as severe dementia, poor cognition, poor cooperation and motivation, poor family support
5. ESRD on Hemodialysis
Minimum Eligible Age

60 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Taipei City Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

MUJUNG KAO

Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MUJUNG KAO, MD

Role: PRINCIPAL_INVESTIGATOR

Taipei City Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Taipei City Hospital

Taipei, Taiwan, Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

MUJUNG KAO, MD

Role: CONTACT

Phone: 0919060998

Email: [email protected]

KUNHUA HUANG, BS

Role: CONTACT

Phone: 0979309125

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

MUJUNG KAO, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TCHIRB-1020430

Identifier Type: -

Identifier Source: org_study_id